Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy

Biotherapy

Volumn 9, Issue 1-3, 1996, Pages 117-121

  Pilotti, Vladimiro ^a   Mastrorilli, Mario ^a   Pizza, Giancarlo ^a   De Vinci, Caterina ^b   Busutti, Luciano ^a   Palareti, Aldopaolo ^a   Gozzetti, Giuseppe ^a   Cavallari, Antonino ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

cell mediated immunity; lung cancer; N2 disease; transfer factor

Indexed keywords

TRANSFER FACTOR; TUMOR ANTIGEN;

ADULT; AGED; BLOOD DONOR; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0029751813     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02628668     Document Type: Conference Paper

References (13)

1. Levin AS, Byers VS, Fudenberg HH, Wybran J, Johnston JO & Hackett AJ. Osteogenic sarcoma: immunologie parameters before and during immunotherapy with tumour specific transfer factor. J Clin Inv 1975; 55:487-97.
2. Pizza G, Viza D, Boucheix Cl & Corrado F. In vitro production of a transfer factor specific for transitional cell carcinom of the bladder. Br J Cane 1976; 33(6): 606-12.
3. Pizza G, Viza D, Boucheix C & Corrado F. Effect of in vitro produced transfer factor on the immune response of cancer patients. Eur J Cane 1977; 13(9): 917-23.
4. Pizza G, Viza D, Boucheix Cl & Corrado F: Studies with in vitro produced transfer factor In: Ascher MS, Gottlieb AA, Kirkpatrick CH, eds. Transfer factor: basic properties and clinical applications. New York: Academic Press, 1976:173-85.
5. Humphrey EW, Smart CR & Winchester DP. National survey of the pattern of care for carcinoma of the lung. J Thor Surg 1990; 100: 837-43.
6. Naruke T, Goya T, Tsuchiya R & Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thor Surg 1988; 96:440-47.
7. Kirsh MM, Orringer MB, McAuliffe S, Schork MA, Katz B & Suva J. Transfer factor in the treatment of carcinoma of the lung. Ann Thorac 1984; 38: 140-45.
8. Fujisawa T, Yamaguchi Y, Kimura H, Arita M, Baba M & Shiba M. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer 1984; 54: 663-669.
9. Busutti L, Blotta A, MastrorUli M, Savorani G, Pizza G & De Vinci C. Transfer factor adjuvant therapy in non-small-cell lung carcinoma. (NSCLC) after surgery and radiotherapy. J Exp Path 1987; 3(4); 565-68.
10. Whyte RI, Schork MA, Sloan H, Orringer MB & Kirsh MM. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac 1992; 53(3): 39196.
11. Fujisawa T, Yamaguchi Y, Kimura K, Arita M, Shiba M & Baba M. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn J Surg 1984; 14(6): 452-58.
12. Fujisawa T, Yamaguchi Y & Kimura H. Transfer factor in restoration of cell mediated immunity in lung cancer patients. Jpn J Surg 1983; 13(4): 304-11.
13. Mountain CF: A new international staging system for lung cancer. Chest 1986; 89: 225-233.